Furthermore, significant positive correlations of CBX4 with STAT1 and IL-6R/STAT3 were observed, and the activation of STAT1 and IL-6/STAT3 signaling has been reported to promote immunosuppression in the TME of colon cancer (Zhang et al., 2020). This evidence concerns the gene STAT3 and malignant colon neoplasm.